2019
DOI: 10.1016/j.clnu.2018.02.029
|View full text |Cite
|
Sign up to set email alerts
|

Bioimpedance analysis is safe in patients with implanted cardiac electronic devices

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0
1

Year Published

2019
2019
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(18 citation statements)
references
References 36 publications
0
17
0
1
Order By: Relevance
“…However, BIA is known to be affected by fluid balance [ 4 ], although as technology and datasets develop it may be possible to perform correction calculations for this. BIA is also currently contraindicated in people with implanted cardiac devices; there is increasing evidence that it is likely to be safe [ 15 ], but it is unknown if results can be reliably interpreted.…”
Section: Discussionmentioning
confidence: 99%
“…However, BIA is known to be affected by fluid balance [ 4 ], although as technology and datasets develop it may be possible to perform correction calculations for this. BIA is also currently contraindicated in people with implanted cardiac devices; there is increasing evidence that it is likely to be safe [ 15 ], but it is unknown if results can be reliably interpreted.…”
Section: Discussionmentioning
confidence: 99%
“…The use of BIVA in patients having CIEDs is limited because of concerns about electromagnetic interference. However, a study of 200 patients from France indicated that there were no significant changes in battery lead impedance, voltage, or pacing thresholds during BIVA ( 31 ). In addition, no changes in CIEDs were found at 0.5 and 1 year of follow-up ( 31 ), suggesting that BIVA performance in patients having CIEDs is secure.…”
Section: Clinical Application Of Bivamentioning
confidence: 99%
“…However, a study of 200 patients from France indicated that there were no significant changes in battery lead impedance, voltage, or pacing thresholds during BIVA ( 31 ). In addition, no changes in CIEDs were found at 0.5 and 1 year of follow-up ( 31 ), suggesting that BIVA performance in patients having CIEDs is secure. A study that included 43 patients from Brazil demonstrated that there were significant reductions in BIVA parameters, including reactance, resistance, and measurements after CIEDs were implanted ( 41 ).…”
Section: Clinical Application Of Bivamentioning
confidence: 99%
“…Bioimpedance analysis is a promising form of telemonitoring with great potential; however, there is a lack of evidence for such a technology for remote patient monitoring. Moreover, until now, bioimpedance analysis has been contraindicated in patients implanted with pacemakers, even if numerous studies were able to demonstrate a high level of safety and no adverse events in this population of patients [109][110][111].…”
Section: What Needs To Be Changed or Improved?mentioning
confidence: 99%